Holiday
humor from STAT News includes a piece outlining ICD-10 medical codes for
typical holiday health problems. If you’re looking for them, STAT has the codes for holiday injuries (contact with electric knife, struck by turkey), stress
of waiting for Santa (behavioral insomnia of childhood, encounter for
examination of eyes and vision with abnormal findings), and “holiday relief
(Z75.5)”. May you and yours have lots of Z75.5 this holiday season.
Friday, December 23, 2016
Wednesday, December 21, 2016
Help build trust in CT health policymaking – take a quick survey
Health reform offers Connecticut exciting opportunities to
improve our troubled health care systems, but also daunting challenges. In
several health policy circles, a lack of trust has been suggested as a barrier
to progress. We are seeking thoughts and ideas to build trust across
Connecticut’s health care system. Please take a very short confidential survey to
contribute your ideas and thoughts.
Friday, December 16, 2016
CT among highest states in opioid-related hospital visits but rising more slowly than most states
In 2014, Connecticut’s per capita rate of opioid-related ED
visits was 37% higher than the national average and our inpatient visit rate was
28% higher according to a new report
by AHRQ. While those rates grew between 2009 and 2014 in almost every state,
Connecticut’s growth rates were among the lowest in the nation. Opioid-related
ED visits per capita grew by 51% compared to the national average of 65.5% and
our inpatient rates grew by 29%, very close to the national rate. Connecticut
is joined by other northeastern states with high opioid-related hospital visit
rates. Massachusetts had by far the highest ED rates in 2014 at two and a half
times the national rate. Maryland topped the list for opioid-related inpatient stays.
Thursday, December 15, 2016
CSG, ERC pass resolutions to preserve Medicaid state-federal partnership
At our meetings in Virginia last week, both the National
and Eastern
Region Council of State Governments passed resolutions urging federal
policymakers to support and continue the successful Medicaid state-federal
partnership and “avoid the imposition of new burdens on state budgets.” The
resolutions are in response
to signals from the incoming federal administration and Congress to place
new limits on Medicaid funding to states combined with more flexibility operating
the program. In Connecticut,
Medicaid covers one in five state residents, including 186,967 people newly
eligible under the Affordable Care Act, brings $4.6 billion in health funding to
the state and comprises 23.2% of the state’s budget.
Wednesday, December 14, 2016
Health Care Cabinet finalizes controversial report recommendations for reform with tight votes
At yesterday’s meeting, the Health Care Cabinet took a final
vote on controversial
recommendations to reform our state’s health system. The main concern that
garnered the most
disagreement and public
input was a recommendation to place all Medicaid and state employees in a downside
risk payment model within four years. While the measure still passed, the
vote was close at 11 to 8. Three members changed their votes to oppose the
measure – Frances Padilla of the Universal Health Care Foundation of
Connecticut, Josh Wojick of the State Comptroller’s Office and Dr. William
Handelman, former President of the CT State Medical Society. Rev. Bonita Grubbs
also voted against the measure, as she was not able to attend the previous
vote. They joined the four
previous no votes on the recommendation from OPM, DSS, DPH and the CT
Health Policy Project. The Cabinet’s vote in favor of downside risk on an aggressive
timeline stands in contrast to comments submitted by CT’s
Medicaid and Behavioral
Health oversight councils and the overwhelming majority of public input
received at the Cabinet’s public hearing which ran three to one against the
proposal. A minority
report opposing downside risk and other recommendations was added to the final
draft. Other proposals also garnered significant opposition including a tie
on whether to set targets for value-based purchasing contracts.
Monday, December 5, 2016
CT Health Reform Dashboard responds to eroding accountability in hospital oversight and Medicaid consumer rights
This month’s Health Reform Dashboard
update once again reflects more attempts to unravel progress in CT. Medicaid leads the concerns with the success
of new ACOs at the last minute in blowing up federally required consumer
notices that were carefully negotiated over months, so that consumers will need
a college education to understand the risks of underservice and adverse
selection or how to protect themselves. This is in addition to the
administration’s broken
promises on downside risk and a reversal on whether to conduct or act on a
meaningful evaluation of the new Medicaid shared savings program. Other
concerns include poor choices for monitors and consultants to oversee Yale-New
Haven’s acquisition of L&M’s health system, the Health Care Cabinet
continues to consider troubling
reform recommendations for CT and SIM
ethics concerns continue.
Tuesday, November 15, 2016
Healthcare Cabinet gets an earful on reform proposals
At today’s
public hearing, the Cabinet got a lot of thanks for the hard work, but not a
lot of support for the proposals. Unfortunately the meeting was poorly
attended, especially by some of the strongest proponents of downside risk.
Speakers included providers, advocates, a SIM official, a foundation, and business
representatives. Many spoke against downside risk, noting that it could jeopardize
hard-won progress, that it is untested and we should wait and see how current
reforms perform, concerns about changes at the federal level, and that the
looming state budget deficit make any investments unwise. Prospect Medical
Holdings, the for-profit company based in Los Angeles that bought Waterbury
Hospital and ECHN, offered that if the state would give them a capitated fee
for Medicaid and they would save the state millions. They must not be
aware of the “spectacular failure” of capitation in our Medicaid program. Since
we shifted away from capitation, quality and access to care are up, fewer
people are visiting the ER for non-urgent care, and per person costs are down.
Monday, November 14, 2016
Poor choice of monitor in YNHH-L+M deal undermines accountability
Yale-New Haven
Health has chosen Deloitte & Touche to monitor compliance with
conditions of their acquisition of Lawrence + Memorial Healthcare. The
conditions on the unusual acquisition were set in place by the state to protect
prices in the new monopoly market, protect health services for southeastern CT,
oversee promised investments in the region, and to enforce ACA community
benefit requirements. The monitor’s independence, including perceptions, is
crucial to effectiveness. However, YNHH has paid Deloitte over $30 million over
the last ten years in other capacities and Deloitte paid a million dollar fine
to settle charges of violating auditor independence rules in 2015. DPH has already approved the choice but a
diverse coalition of consumers, labor, elected officials, and community
representatives has called on the state to rescind that approval and support an
independent choice in a transparent process. DPH also refused to meet with the
coalition.
Thursday, November 10, 2016
Advocates’ webinar on better alternatives to Health Care Cabinet proposal online
CT’s Health Care Cabinet has voted on a controversial
set of recommendations for reforming our state’s health system. The Cabinet
will take public comment on their plan at a public hearing on Nov. 15th
at 9 am in the LOB. In a webinar yesterday, advocates and others heard about
the plan, better alternatives to downside risk, and the many many issues that
are missing from the Cabinet’s plans. Slides
and a video of the webinar have been
posted online.
Tuesday, November 8, 2016
DSS plans for high-cost, high-need members focuses on behavioral health
At yesterday’s online MAPOC Complex Care Committee meeting, DSS described their innovation plan to address the needs of high-cost, high-need Medicaid members. (meeting video and slides) The project was made possible by a technical assistance grant from the National Governor’s Association. Five agencies and the Medicaid Administrative Service Organizations, CHNCT and Beacon Health, have worked with the committee to identify the top 10% of members – adults and children -- in cost, ED and inpatient use, each separately. Interestingly we found that there is not a lot of overlap between those groups. The top 10 conditions for each of the six categories are listed on the slides. The team then turned to identifying interventions that could have an impact. Consequently the group decided to focus on members with behavioral health needs; many have co-morbid medical conditions. The project will focus on enhanced care management by Beacon Health. 1,236 high-need adults identified from the data will receive intensive care management in the community including intensive outreach from peer counselors to help them develop a personalized care plan and connect them to that care. Yale-New Haven is the highest volume hospital by far with almost four times the number of ED visits and in patient stays as the next highest. Beacon will conduct the evaluation using a matched set of members who do not receive those services due to geography. Questions from the committee included how the state will ensure that the new PCMH+ ACOs do not collect shared savings based on this care coordination funded by the state, measuring connections to primary care, needs of people with intellectual disabiliites, how to address members served by home or nursing home care, and why Yale-New Haven has so many high-utilizing members.
Sunday, November 6, 2016
FDA panel barely approves new antibiotic for pneumonia
Friday, the FDA’s
Antimicrobial Drug Advisory Committee split 7 to 6, to approve
Solithromycin, a new drug for community-acquired pneumonia. Pneumonia is
responsible for 4.5 million ambulatory visits. About half of bacteria causing
pneumonia in the US are now resistant to the best current treatment option. The
committee agreed that the drug was proven effective, but serious concerns were
raised about liver toxicity. The
concerns centered on small sample sizes of clinical trials, troubling liver
enzyme levels in patients, and a scandal
from a decade ago when a similar drug was approved, but was later linked to
deaths from liver failure. The problem is identifying somewhat rare but deadly
adverse events in clinical trials which cannot include enough patients to
detect the problem directly. In the end, most members felt that as bacterial
resistance to antibiotics is rising quickly, we don’t have time to wait for
perfect data.
Thursday, November 3, 2016
Troubling Cabinet vote for downside risk on Medicaid and state employees, but there will be a public hearing
In a 13 to 4 vote Tuesday, the Health Care Cabinet voted to
impose the controversial downside
risk payment model on CT’s Medicaid and state employee plans. DSS, OPM, DPH
and the only consumer advocate at the meeting all voted against the option
(votes are listed below). Deep
concerns have been raised about downside risk including underservice
incentives to deny necessary treatments, incentives to avoid costly patients, and
disincentives to even tell people about treatments that may be costly. The
Cabinet’s proposal includes no mention of even monitoring for underservice. Other
downside risk concerns include a broken
promise, disincentives to invest in quality, it is very new and
experimental, it is based on extrapolating economic theory from very different
subjects, and providers are widely rejecting it in other states. In many ways
downside risk is worse than capitation, which “failed spectacularly” in CT.
Other troubling options endorsed by the Cabinet include creation
of a costly Office of Health Strategy, giving the Attorney General subpoena
power to monitor health market trends, to study applying for a costly Medicaid
1115 waiver with a risky DSRIP option to implement downside risk, and to create
a new comparative effectiveness committee to make recommendations about which
treatments should be approved in CT. In good news, the Cabinet did endorse
creation of community health teams to connect medical care with public health
and social services. The concept is modeled on Vermont’s
successful Blueprint for Health program.
A troubling plan to create a state agency-only Health
Planning Council was scrapped when concerns about open meeting/Freedom of
Information laws reached
social media during the meeting.
The Cabinet will take public comment on their plan at a
public hearing on Nov. 15th at 9 am in the LOB. Advocates are
invited to hear more in a webinar November 9th at 2 pm about the
plan, better alternatives to downside risk, and the many many issues that are
missing from the Cabinet’s plans. Click here
to register for the webinar.
Cabinet members’ organizations and votes on downside risk are
listed below. For links to the vote tally click
here and the voting guide click
here. * indicates funders of the Cabinet consultants who developed the plan.
The votes are provisional; they may be changed after the public hearing Nov. 15th.
Voted against
downside risk
|
Office of Policy and Management
|
Dept. of Social Services
|
Dept. of Public Health
|
CT Health Policy Project
|
Voted for downside
risk
|
Office of State Comptroller
|
Acting State Healthcare Advocate
|
AccessHealthCT
|
CT Pharmacists Association
|
Bristol Hospital
|
TR Paul, Inc.
|
CT Coalition of Taft-Hartley Health Funds
|
Universal Healthcare Fndn of CT*
|
CT Health Fndn*
|
Bill Handleman, MD
|
Gary Letts, MD
|
Masonicare
|
Hussam Saada
|
Wednesday, November 2, 2016
Nominations open for New England comparative effectiveness council
The Institute
for Clinical and Economic Review is seeking new members for the New England
Comparative Effectiveness Public Advisory Council, in addition to two other councils
in California and the Midwest. Many health policy experts blame new
technologies for drugs, devices and other innovations with driving health costs
up without necessarily improving the quality of care. The Councils include
leading clinician, patient and public representatives, researchers, and health
economists who meet a few times a year to consider, and vote on, the
effectiveness and value of new health treatments. Previous topics include
treatments for liver disease, multiple myeloma, and lung cancer, as well as
system-level interventions such as palliative care and diabetes prevention
programs. Members must meet conflict of interest guidelines and will be
reimbursed for travel to meetings and for their time. To apply, send a
CV/resume and letter of interest to info@icer-review.org
by December 15th. Learn more about ICER here,
here
and here.
Monday, October 31, 2016
CT Health Reform Dashboard responds to efforts to undermine constructive policies
This month’s Health Reform Dashboard
update reflects more attempts to unravel progress in CT. Medicaid leads the concerns with broken
promises on downside risk and attempts to weaken critical consumer notices
about shifting provider incentives, potential underservice, and how to protect
yourself. OHCA’s approval of YNHH’s acquisition of L&M health system will
require a lot of unusual regulatory oversight and political will. The Health
Care Cabinet continues to consider troubling
reform recommendations for CT and SIM
ethics concerns continue, especially in efforts to weaken Medicaid shared
savings consumer notices.
Subscribe to:
Posts (Atom)